High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients
NCT: NCT06897319 · NOT_YET_RECRUITING
Brief Summary
This monocentric, randomized crossover study aims to assess the impact of high-flow tracheal therapy (HFT) on the rheological properties of tracheobronchopulmonary secretions in tracheostomized patients. The primary objective is to compare the viscoelastic characteristics of secretions collected with and without HFT. Secondary objectives include evaluating the effects of HFT on dyspnea, patient comfort, and secretion appearance. The study will take place at Cliniques Universitaires Saint-Luc, with adult tracheostomized patients undergoing standard care.
Frequently Asked Questions
What is High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients?
High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients is a clinical trial registered under NCT06897319. Current status: NOT_YET_RECRUITING.
What is the status of NCT06897319?
The current status of NCT06897319 (High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients) is: NOT_YET_RECRUITING.
When did High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients start?
High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients started on 2026-06-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.